Successful treatment of chronic refractory pouchitis with vedolizumab

International Journal of Colorectal Disease

Volumn 32, Issue 10, 2017, Pages 1517-1518

  Mir, Fazia ^a   Yousef, Mohamad Hasan ^a   Partyka, Edward Kenneth ^a   Tahan, Veysel ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; COCODAMOL; COLESTYRAMINE; HYOSCYAMINE; INFLIXIMAB; KEFIR; LOPERAMIDE; MESALAZINE; METRONIDAZOLE; PROBIOTIC AGENT; RIFAXIMIN; VEDOLIZUMAB; MONOCLONAL ANTIBODY;

ABDOMINAL PAIN; ADULT; CASE REPORT; CHRONIC ANTIBIOTIC REFRACTORY POUCHITIS; CHRONIC DIARRHEA; CHRONIC DISEASE; CLINICAL ARTICLE; DRUG TREATMENT FAILURE; DUODENUM BIOPSY; ERYTHEMA; FEMALE; HUMAN; HUMAN TISSUE; ILEITIS; LETTER; PRIORITY JOURNAL; PROCTOCOLECTOMY; QUALITY OF LIFE; ULCER; ULCERATIVE COLITIS; WEIGHT REDUCTION;

ANTIBODIES, MONOCLONAL, HUMANIZED; CHRONIC DISEASE; COLITIS, ULCERATIVE; HUMANS; POUCHITIS; PROCTOCOLECTOMY, RESTORATIVE;

EID: 85023186729     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-017-2854-0     Document Type: Letter

References (4)

1. Schmid M, Frick JS, Malek N, Goetz M (2017) Successful treatment of pouchitis with vedolizumab, but not fecal microbiota transfer (FMT), after proctocolectomy in ulcerative colitis. Int J Color Dis 32(4):597–598
2. Shen B (2012) Acute and chronic pouchitis—pathogenesis, diagnosis and treatment. Nat Rev Gastroenterol Hepatol 9(6):323–333
3. Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel JF, Sandborn WJ, Van Assche G, Axler J, Kim HJ, Danese S, Fox I, Milch C, Sankoh S, Wyant T, Xu J, Parikh A; GEMINI 1 Study Group. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med 2013;369(8):699–710
4. Philpott J, Ashburn J, Shen B (2017) Efficacy of vedolizumab in patients with antibiotic and anti-tumor necrosis alpha refractory pouchitis. Inflamm Bowel Dis 23(1):E5–E6